Leap Therapeutics Inc (LPTX)

Currency in USD
0.3340
-0.0056(-1.65%)
Closed·
Pre Market
0.3201-0.0139(-4.16%)
·
LPTX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
LPTX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.32840.3560
52 wk Range
0.22234.7900
Key Statistics
Prev. Close
0.334
Open
0.356
Day's Range
0.3284-0.356
52 wk Range
0.2223-4.79
Volume
342.79K
Average Volume (3m)
1.29M
1-Year Change
-84.47%
Book Value / Share
0.51
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LPTX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.0000
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Leap Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Leap Therapeutics Inc Company Profile

Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead clinical stage drug candidate includes DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in various ongoing clinical trials for treating esophagogastric and gynecologic cancers, and colorectal cancer. The company also develops FL-501, a monoclonal antibody that inhibits GDF-15 protein that is in preclinical trial. It has an option and license agreement with Adimab, LLC and BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.

Compare LPTX to Peers and Sector

Metrics to compare
LPTX
Peers
Sector
Relationship
P/E Ratio
−0.2x−4.4x−0.5x
PEG Ratio
−0.010.030.00
Price/Book
0.7x3.3x2.6x
Price / LTM Sales
-192.5x3.2x
Upside (Analyst Target)
-167.9%42.0%
Fair Value Upside
Unlock8.3%6.6%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 0.0000

Earnings

Latest Release
May 13, 2025
EPS / Forecast
-0.37 / -0.40
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

LPTX Income Statement

People Also Watch

0.815
WINT
-11.41%
0.96
KLTO
-15.04%
0.3989
VXRT
-1.51%
3.16
INMB
+8.59%
32.00
BMNR
-8.86%

FAQ

What Stock Exchange Does Leap Therapeutics Trade On?

Leap Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Leap Therapeutics?

The stock symbol for Leap Therapeutics is "LPTX."

What Is the Leap Therapeutics Market Cap?

As of today, Leap Therapeutics market cap is 13.84M.

What Is Leap Therapeutics's Earnings Per Share (TTM)?

The Leap Therapeutics EPS (TTM) is -1.69.

From a Technical Analysis Perspective, Is LPTX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Leap Therapeutics Stock Split?

Leap Therapeutics has split 1 times.

How Many Employees Does Leap Therapeutics Have?

Leap Therapeutics has 26 employees.

What is the current trading status of Leap Therapeutics (LPTX)?

As of 30 Jul 2025, Leap Therapeutics (LPTX) is trading at a price of 0.33, with a previous close of 0.33. The stock has fluctuated within a day range of 0.33 to 0.36, while its 52-week range spans from 0.22 to 4.79.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.